Cargando…

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study

KEY POINTS: A single bolus of tinzaparin is effective for 8-hour hemodialysis session. Eight-hour simulation sessions with anti-Xa monitoring are useful to adjust tinzaparin dose. BACKGROUND: Few studies have assessed the use of low-molecular weight heparins for anticoagulation during extended hemod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harvey, Benoît, Lafrance, Jean-Philippe, Elftouh, Naoual, Vallée, Michel, Laurin, Louis-Philippe, Nadeau-Fredette, Annie-Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278850/ https://www.ncbi.nlm.nih.gov/pubmed/36921585 http://dx.doi.org/10.34067/KID.0000000000000098

Ejemplares similares

Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk
por: Leclerc, Simon, et al.
Publicado: (2020)

Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients
por: Bénard, Valérie, et al.
Publicado: (2019)

Assisted Peritoneal Dialysis Implementation: A Pilot Program From a Large Dialysis Unit in Quebec
por: Melanson, Julien, et al.
Publicado: (2022)

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center
por: Leclerc, Simon, et al.
Publicado: (2021)

Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case–control study
por: Harrak, Hind, et al.
Publicado: (2015)

Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients
por: Lessard, Myriam, et al.
Publicado: (2014)

Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study
por: Lazrak, Hind H., et al.
Publicado: (2018)

Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study
por: Harrak, Hind, et al.
Publicado: (2020)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
por: Lazrak, Hind Harrak, et al.
Publicado: (2017)

Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

An Unusual Initial Presentation of Lupus Nephritis as a Renal Mass
por: Goupil, Remi, et al.
Publicado: (2015)

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
por: Mahmood, Dana, et al.
Publicado: (2010)

The Role of Tinzaparin in Oncology
por: Dimakakos, Evangelos P., et al.
Publicado: (2017)

Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin
por: Nikolakopoulos, Konstantinos M., et al.
Publicado: (2018)

Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
por: Giroux, Marjolaine, et al.
Publicado: (2021)

The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
por: Alsalemi, Noor, et al.
Publicado: (2022)

A virtual ward for home hemodialysis patients – a pilot trial
por: Raphael, Michael J., et al.
Publicado: (2015)

Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2014)

Optimization of Dialysis Modality Transitions for Improved Patient Care
por: Imbeault, Benoit, et al.
Publicado: (2019)

Kidney Biopsy Findings Among Allogenic Hematopoietic Stem Cell Transplant Recipients With Kidney Injury: A Case Series
por: Roy, Guillaume, et al.
Publicado: (2023)

Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021)

Home Hemodialysis and Peritoneal Dialysis Patient and Technique Survival in Canada
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2020)

Feasibility of Dialysate Bolus-Based Absolute Blood Volume Estimation in Maintenance Hemodialysis Patients
por: Krenn, Simon, et al.
Publicado: (2022)

Heparin/tinzaparin-sodium: Lack of efficacy: 3 case reports
Publicado: (2020)

Tinzaparin-sodium: Bleeding and deep venous thrombosis: case report
Publicado: (2022)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023)

A prophylactic subcutaneous dose of the anticoagulant tinzaparin does not influence qPCR-based assessment of circulating levels of miRNA in humans
por: Nilsson, Abraham, et al.
Publicado: (2022)

Accessing hemodialysis clinics during the COVID-19 pandemic
por: Beaudet, Matthew, et al.
Publicado: (2022)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey
por: Beaubien-Souligny, William, et al.
Publicado: (2021)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant
por: Malyszko, Jolanta, et al.
Publicado: (2017)

Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin
por: Borman, Natalie, et al.
Publicado: (2010)

Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses
por: Amerali, Marina, et al.
Publicado: (2022)

Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2022)

Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis
por: Goupil, Rémi, et al.
Publicado: (2021)

Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
por: Johansen, Kristian B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3vie2evlucvad4edpscs8rcrt1